Evaluation of The Effect of Loratadine Versus Diosmin/Hesperidin Combination on Vinca Alkaloids Induced Neuropathy

Clinical trial NCT05243706 · UNKNOWN

Trial details

NCT number: NCT05243706
Sponsor: Ain Shams University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Vinca Alkaloid Adverse Reaction

Start date: 2022-03-01
Primary completion: 2023-09-30
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.